人参环氧炔醇治疗阿尔茨海默病的作用机制研究

doi:10.3969/j.issn.1004-616x.2025.03.004

摘要/Abstract

摘要： 目的：采用网络药理学分析结合分子对接、体外细胞实验探讨人参环氧炔醇(PND)治疗阿尔茨海默病的作用机制，并验证其对神经细胞的保护作用。方法：基于PharmMapper、GeneCards、STRING等数据库筛选PND治疗阿尔茨海默病的作用靶点并构建蛋白质相互作用网络，通过 GO 及 KEGG 通路富集分析明确特征通路，并利用分子对接技术进行验证。用人神经母细胞瘤SH-SY5Y细胞建立L-谷氨酸诱导的细胞损伤模型，实验组细胞加入不同浓度的PND(10、20、40 μmol/L)预处理，采用CCK-8法检测细胞活性，流式细胞术检测细胞凋亡情况。结果：构建PND-核心靶点-特征通路-阿尔茨海默病网络，发现PND调控的重要核心靶点包括ALB、AKT1、EGFR、SRC、CASP3、NFKB1、PTGS2、PPARG等，特征通路涉及EGFR通路、C型凝集素受体信号通路、RAS信号通路、PI3K-Akt信号通路和阿尔茨海默病信号通路；分子对接结果表明PND对CYP3A4、APP、EGFR等靶点具有较好的调控作用。体外细胞实验结果显示，L-谷氨酸诱导的神经损伤模型组 SH-SY5Y 细胞存活率较对照组降低(P<0.01)，20 μmol/L PND预处理组细胞存活率高于模型组(P<0.01)；模型组神经细胞总凋亡率为45.23%，10、20、40 μmol/L PND预处理组细胞的凋亡率分别为41.34%、36.96%和21.86%，均低于模型组(P<0.05或P<0.01)。结论：PND具有神经保护作用，并可能通过保护神经细胞从而起到治疗阿尔茨海默病的作用。

关键词: 人参环氧炔醇, 网络药理学, 阿尔茨海默病, 神经保护

Abstract: OBJECTIVE： To use network pharmacology analysis together with molecular docking and in vitro cell experiments for evaluating therapeutic potential of ginseng cyclopentadienol (PND) on Alzheimer's disease，and for understanding its protective effect on neurons. METHODS： Targets of PND in the treatment of Alzheimer' s disease were screened based on PharmMapper， GeneCards， STRING and other databases， and a protein interaction network was constructed. Characteristic pathways were identified by GO and KEGG pathway enrichment analysis and then verified by molecular docking technology. An L-glutamate-induced cell injury model was established using human neuroblastoma SH-SY5Y cells. After treatment of these cells with different concentrations of PND (10，20，40 μmol/L)， cell activity was detected by CCK-8 method，and apoptosis was detected by flow cytometry. RESULTS： A PND-core target-characteristic pathway-Alzheimer's disease network was constructed， and the important targets regulated by PND were found to be ALB， AKT1， EGFR， SRC， CASP3， NFKB1， PTGS2， PPARG， etc. Multiple pathways were identified to involve EGFR， C-type lectin receptor signaling，RAS signaling，PI3K-Akt signaling and Alzheimer's disease signaling. The molecular docking results showed that PND had a good regulatory effect on targets such as CYP3A4，APP，and EGFR. Results from the in vitro cell experiments showed that the survival rate of SH-SY5Y cells in the L-glutamate-induced nerve injury model group was reduced，and the cell survival rate in the 20 μmol/L PND treatment group was higher than that in the model group (P<0.01)；the total apoptosis rate of nerve cells in the model group was 45.23%，and the apoptosis rates of cells in the 10，20 and 40 μmol/L PND treatment groups were 41.34%， 36.96% and 21.86% ， respectively， which were lower than those in the model group (P<0.05 or P<0.01). CONCLUSION： PND showed a neuroprotective effect which may be useful for treatment of Alzheimer's disease.

Key words: panaxydol, network pharmacology, Alzheimer's disease, neuroprotection

中图分类号:

R285.5

张尉江, 杨洁, 于智颖, 贺江华, 徐文娟. 人参环氧炔醇治疗阿尔茨海默病的作用机制研究[J]. 癌变·畸变·突变, 2025, 37(3): 196-201.

ZHANG Weijiang, YANG Jie, YU Zhiying, HE Jianghua, XU Wenjuan. Therapeutic potential of panaxydol on Alzheimer's disease[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2025, 37(3): 196-201.

参考文献

[1] 马传金, 高丽雯, 张小静, 等. CDDO-E6对 L-谷氨酸诱导SH-SY5Y神经细胞损伤的保护作用[J]. 江苏医药, 2016, 42(11): 1218-1221.
[2] PLATT S R. The role of glutamate in central nervous system health and disease: a review[J]. Vet J, 2007, 173(2): 278-286.
[3] STOJANOVIC I R, KOSTIC M, LJUBISAVLJEVIC S. The role of glutamate and its receptors in multiple sclerosis[J]. J Neural Transm, 2014, 121(8): 945-955.
[4] 宋莉. 人参环氧炔醇对人肝癌细胞株HepG2、SMMC-7721的诱导分化作用[D]. 上海: 上海交通大学, 2007.
[5] 蔡锦贤, 荆晶, 陆阳. 天然聚乙炔醇的研究进展[J]. 中草药, 2007, 38(4): 620-623.
[6] NIE B M, YANG L M, FU S L, et al. Protective effect of panaxydol and panaxynol on sodium nitroprusside-induced apoptosis in cortical neurons[J]. Chem Biol Interact, 2006, 160(3): 225-231.
[7] LIU X F, OUYANG S S, YU B, et al. PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach[J]. Nucleic Acids Res, 2010, 38(suppl_2): W609-W614.
[8] WANG X, PAN C X, GONG J Y, et al. Enhancing the enrichment of pharmacophore-based target prediction for the polypharmacological profiles of drugs[J]. J Chem Inf Model, 2016, 56(6): 1175-1183.
[9] WANG X, SHEN Y H, WANG S W, et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database[J]. Nucleic Acids Res, 2017, 45(W1): W356-W360.
[10] WANG J C, CHU P Y, CHEN C M, et al. idTarget: a web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach[J]. Nucleic Acids Res, 2012, 40(Web Server issue): W393-W399.
[11] KNOX C, WILSON M, KLINGER C M, et al. DrugBank 6.0: the DrugBank knowledgebase for 2024[J]. Nucleic Acids Res, 2024, 52(D1): D1265-D1275.
[12] BERMAN H, HENRICK K, NAKAMURA H. Announcing the worldwide protein data bank[J]. Nat Struct Biol, 2003, 10(12): 980.
[13] 汪麟双. 参芪益智颗粒治疗阿尔茨海默病的作用机制研究[D]. 北京: 中国中医科学院, 2023.
[14] 吴东霖, 张鼎, 秦红玲, 等. 基于网络药理学与分子对接技术探讨蛇床子治疗阿尔茨海默病的作用机制[J]. 现代药物与临床, 2024, 39(3): 570-577.
[15] NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION. NFE2L2: PubChem Gene Summary for Gene 4780, NFE2L2- NFE2 like bZIP transcription factor 2(human) [DS/OL]. [2024- 09-27]. https: //pubchem.ncbi.nlm.nih.gov/gene/NFE2L2/human.
[16] NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION. PubChem Gene Summary for Gene 3320, HSP90AA1-heat shock protein 90 alpha family class A member 1(human) [DS/ OL]. [2024-09-27]. https: //pubchem.ncbi.nlm.nih.gov/gene/ HSP90AA1/human.
[17] NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION. PubChem Gene Summary for Gene 351, APP-amyloid beta precursor protein (human) [DS/OL]. [2024-09-27]. https: // pubchem.ncbi.nlm.nih.gov/gene/APP/human.
[18] NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION. PubChem Pathway Summary for Pathway SMP0063784, Ras Signaling Pathway[DS/OL]. [2024-09-27].https: //pubchem. ncbi.nlm.nih.gov/pathway/PathBank: SMP0063784.
[19] NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION. PubChem Pathway Summary for Pathway WP4806, EGFR tyrosine kinase inhibitor resistance [DS/OL]. [2024-09-27]. https: //pubchem.ncbi.nlm.nih.gov/pathway/WikiPathways: WP4806.
[20] GUO L C, SONG L, WANG Z J, et al. Panaxydol inhibits the proliferation and induces the differentiation of human hepatocarcinoma cell line HepG2[J]. Chem Biol Interact, 2009, 181(1): 138-143.
[21] ZHU H, WANG W J, DING W L, et al. Effect of panaxydol on hypoxia-induced cell death and expression and secretion of neurotrophic factors (NTFs) in hypoxic primary cultured Schwann cells[J]. Chem Biol Interact, 2008, 174(1): 44-50.